BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 15862132)

  • 1. APF, HB-EGF, and EGF biomarkers in patients with ulcerative vs. non-ulcerative interstitial cystitis.
    Zhang CO; Li ZL; Kong CZ
    BMC Urol; 2005 Apr; 5():7. PubMed ID: 15862132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor as urine markers for interstitial cystitis.
    Keay SK; Zhang CO; Shoenfelt J; Erickson DR; Whitmore K; Warren JW; Marvel R; Chai T
    Urology; 2001 Jun; 57(6 Suppl 1):9-14. PubMed ID: 11378043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bladder stretch alters urinary heparin-binding epidermal growth factor and antiproliferative factor in patients with interstitial cystitis.
    Chai TC; Zhang CO; Shoenfelt JL; Johnson HW; Warren JW; Keay S
    J Urol; 2000 May; 163(5):1440-4. PubMed ID: 10751853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor in men with interstitial cystitis versus chronic pelvic pain syndrome.
    Keay S; Zhang CO; Chai T; Warren J; Koch K; Grkovic D; Colville H; Alexander R
    Urology; 2004 Jan; 63(1):22-6. PubMed ID: 14751340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bladder epithelial cells from patients with interstitial cystitis produce an inhibitor of heparin-binding epidermal growth factor-like growth factor production.
    Keay S; Kleinberg M; Zhang CO; Hise MK; Warren JW
    J Urol; 2000 Dec; 164(6):2112-8. PubMed ID: 11061938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of APF activity and epithelial growth factor levels in urine from Chinese, African-American, and white American patients with interstitial cystitis.
    u Zhang CO; Li ZL; Shoenfelt JL; Kong CZ; Chai TC; Erickson DR; Peters KM; Rovner ES; Keay S
    Urology; 2003 May; 61(5):897-901. PubMed ID: 12735999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous sacral third nerve root neurostimulation improves symptoms and normalizes urinary HB-EGF levels and antiproliferative activity in patients with interstitial cystitis.
    Chai TC; Zhang C; Warren JW; Keay S
    Urology; 2000 May; 55(5):643-6. PubMed ID: 10792070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentrations of specific epithelial growth factors in the urine of interstitial cystitis patients and controls.
    Keay S; Zhang CO; Kagen DI; Hise MK; Jacobs SC; Hebel JR; Gordon D; Whitmore K; Bodison S; Warren JW
    J Urol; 1997 Nov; 158(5):1983-8. PubMed ID: 9334654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective evaluation of candidate urine and cell markers in patients with interstitial cystitis enrolled in a randomized clinical trial of Bacillus Calmette Guerin (BCG).
    Keay S; Reeder JE; Koch K; Zhang CO; Grkovic D; Peters K; Zhang Y; Kusek JW; Nyberg LM; Payne CK; Propert KJ
    World J Urol; 2007 Oct; 25(5):499-504. PubMed ID: 17694391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-binding epidermal growth factor-like growth factor functionally antagonizes interstitial cystitis antiproliferative factor via mitogen-activated protein kinase pathway activation.
    Kim J; Keay SK; Freeman MR
    BJU Int; 2009 Feb; 103(4):541-6. PubMed ID: 18990151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptom profile variability of interstitial cystitis/painful bladder syndrome by age.
    Rais-Bahrami S; Friedlander JI; Herati AS; Sadek MA; Ruzimovsky M; Moldwin RM
    BJU Int; 2012 May; 109(9):1356-9. PubMed ID: 21883848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential urine and serum biomarkers for patients with bladder pain syndrome/interstitial cystitis.
    Kuo HC
    Int J Urol; 2014 Apr; 21 Suppl 1():34-41. PubMed ID: 24807491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal Akt signalling in bladder epithelial cell explants from patients with interstitial cystitis/bladder pain syndrome can be induced by antiproliferative factor treatment of normal bladder cells.
    Keay SK; Zhang CO
    BJU Int; 2016 Jul; 118(1):161-72. PubMed ID: 26919663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for interstitial cystitis/painful bladder syndrome.
    Argade S; Chermansky C; Tyagi P
    Womens Health (Lond); 2016 Jan; 12(1):87-90. PubMed ID: 26696241
    [No Abstract]   [Full Text] [Related]  

  • 15. Decreased in vitro proliferation of bladder epithelial cells from patients with interstitial cystitis.
    Keay S; Zhang CO; Shoenfelt JL; Chai TC
    Urology; 2003 Jun; 61(6):1278-84. PubMed ID: 12809929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproliferative activity is present in bladder but not renal pelvic urine from interstitial cystitis patients.
    Keay S; Warren JW; Zhang CO; Tu LM; Gordon DA; Whitmore KE
    J Urol; 1999 Oct; 162(4):1487-9. PubMed ID: 10492242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cystoscopy in the diagnosis of Hunner's ulcer disease.
    Braunstein R; Shapiro E; Kaye J; Moldwin R
    J Urol; 2008 Oct; 180(4):1383-6. PubMed ID: 18707698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome.
    Erickson DR; Tomaszewski JE; Kunselman AR; Stetter CM; Peters KM; Rovner ES; Demers LM; Wheeler MA; Keay SK
    J Urol; 2008 May; 179(5):1850-6. PubMed ID: 18353383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
    Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
    Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are ulcerative and nonulcerative interstitial cystitis/painful bladder syndrome 2 distinct diseases? A study of coexisting conditions.
    Peters KM; Killinger KA; Mounayer MH; Boura JA
    Urology; 2011 Aug; 78(2):301-8. PubMed ID: 21703668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.